medigraphic.com
ISSN 2683-1678 (Print)
Órgano Oficial de la Sociedad
Latinoamericana de lnfectología Pediátrica.
Órgano de la Asociación Mexicana de
Infectología Pediátrica, A.C.
Órgano difusor de la Sociedad Española
de lnfectología

2017, Number 3

<< Back Next >>

Rev Latin Infect Pediatr 2017; 30 (3)

Streptococcus pyogenes toxic shock syndrome: case report and literature review

González SN, Vega CR, Romero RL, Gómez TV

Language: Spanish
References: 13
Page: 116-121
PDF size: 266.92 Kb.


ABSTRACT

One of the most severe diseases caused by Streptococcus pyogenes is toxic shock syndrome, first described in 1978 and classically associated with some predisposing factors such as chickenpox or tampon use. It is defined as shock with multiple organ failure acutely triggered by this agent, most of the time in immunocompetent patients. Its evolution is so severe that the patients may die in the first 48 hours due to the inflammatory response secondary to the host’s immune response against the bacteria and its toxin. A female case with this syndrome without the previously described predisposing factors is presented, and a brief revision of the literature is done.


REFERENCES

  1. Sanderson-Smith M, De Oliveira DM, Guglielmini J, McMillan DJ, Vu T, Holien JK et al. A systematic and functional classification of Streptococcus pyogenes that serves as a new tool for molecular typing and vaccine development. J Infect Dis. 2014; 210 (8): 1325-1338.

  2. Filleron A, Jeziorski E, Michon AL, Rodière M, Marchandin H. Current insights in invasive group A streptococcal infections in pediatrics. Eur J Pediatr. 2012; 171 (11): 1589-1598.

  3. Larru B, Gerber JS. Cutaneous bacterial infections caused by Staphylococcus aureus and Streptococcus pyogenes in infants and children. Pediatr Clin North Am. 2014; 61 (2): 457-478.

  4. Zachariadou L, Stathi A, Tassios PT, Pangalis A, Legakis NJ, Papaparaskevas J et al. Differences in the epidemiology between paediatric and adult invasive Streptococcus pyogenes infections. Epidemiol Infect. 2014; 142 (3): 512-519.

  5. Loof TG, Rohde M, Chhatwal GS, Jung S, Medina E. The contribution of dendritic cells to host defenses against Streptococcus pyogenes. J Infect Dis. 2007; 196 (12): 1794-1803.

  6. Johansson L, Norrby-Teglund A. Immunopathogenesis of streptococcal deep tissue infections. Curr Top Microbiol Immunol. 2013; 368: 173-188.

  7. Medina E, Goldmann O, Toppel AW, Chhatwal GS. Survival of Streptococcus pyogenes within host phagocytic cells: a pathogenic mechanism for persistence and systemic invasion. J Infect Dis. 2003; 187 (4): 597-603.

  8. Cole JN, Barnett TC, Nizet V, Walker MJ. Molecular insight into invasive group A streptococcal disease. Nat Rev Microbiol. 2011; 9 (10): 724-736.

  9. Ramachandran G, Tulapurkar ME, Harris KM, Arad G, Shirvan A, Shemesh R et al. A peptide antagonist of CD28 signaling attenuates toxic shock and necrotizing soft-tissue infection induced by Streptococcus pyogenes. J Infect Dis. 2013; 207 (12): 1869-1877.

  10. Steer AC, Lamagni T, Curtis N, Carapetis JR. Invasive group a streptococcal disease: epidemiology, pathogenesis and management. Drugs. 2012; 72 (9): 1213-1227.

  11. Low DE. Toxic shock syndrome: major advances in pathogenesis, but not treatment. Crit Care Clin. 2013; 29 (3): 651-675.

  12. Lithgow A, Duke T, Steer A, Smeesters PR. Severe group A streptococcal infections in a paediatric intensive care unit. J Paediatr Child Health. 2014; 50 (9): 687-692.

  13. Zimbelman J, Palmer A, Todd J. Failure of beta-lactam antibiotics (eagle effect) and superiority of clindamycin in the treatment of invasive Streptococcus pyogenes infections. Pediatric Research. 1998; 43: 161-161.




2020     |     www.medigraphic.com